The Davis Phinney Foundation is committed to funding the most promising research aimed at therapeutics and lifestyle choices that promote living well with Parkinson’s disease today and every day.
Our investments tend to fall into two areas:
- We invest in programs that can have an immediate impact in the lives of people living with Parkinson’s today.
- We also fund research that explores a range of factors that affect quality of life. Our primary interest is in funding research related to exercise; however, we have also funded research in depression, DBS and speech.
We tend to fund smaller, innovative studies that lead to greater funding. Two of our efforts have followed this path: pilot data generated from a study on depression demonstrated proof of concept and was recently funded by the National Institute of Health; another small study on alpha synuclein resulted in Michael J. Fox Foundation funding.